Opioid Use in Work Comp Injuries Drops 30% Since 2015

Written by on 10/25/2017 1:37 AM in , , , . It has 0 Comments.

In a recent review, The Travelers Companies reported opioid use among more than 500,000 injured workers treated since 2015 has dropped a staggering 30%. How is the insurer forging a new path to successful outcomes without opioids?

The Early Severity Predictor Model
The company’s Early Severity Predictor identifies the probability of an injured worker developing chronic pain, a key cause of opioid dependency. By sharing these results with the injured employee’s physician, other effective treatment alternatives can be sought, such as surgery followed by physical therapy (in lieu of opioids for pain). Such regimens limit exposure to opioids, offering a safer recovery and often producing better long-term medical outcomes.

Impressive Numbers
In addition to the 30% reduction in opioid use, since January 2016 the company’s workers comp cases also saw:
• Surgeries fell by 25%.
• Injured employees receiving alternative treatments recovered and returned to work 10% faster than employees who did not.

Thorough Reviews
The nation’s largest workcomp carrier, Travelers, handles around 250,000 workers comp claims annually. Since the implementation of its Early Severity Predictor model in 2015, in combination with its in-house pharmacy management program, the company has aided employers in reducing medical expenses on identified claims by as much as 50%.

Claims professionals train with on-staff pharmacists, assessing the merits of requests for pharmaceutical reimbursement, ferreting out the potential for overuse and preventing dangerous drug interactions.

Concerned about opioid use affecting the recovery of stellar employees? Opioid use, addiction and overdose cross all ages, genders, and income levels. Do your part in protecting injured workers in light of the nationwide epidemic of opioid overuse and abuse. Learn more from MinnesotaComp Advisor today.

Comments

Got something to say? Join the discussion ยป

Leave a Reply

 [Quick Submit with Ctrl+Enter]

Remember my details
Notify me of followup comments via e-mail